Anti-analgesic activity of enterostatin (VPDPR) is mediated by corticosterone

Peptides

Volumn 24, Issue 5, 2003, Pages 735-739

  Takenaka, Y ^a,d   Nakamura, F ^a,e   Usui, H ^a   Lipkowski, A W ^b   Toth, G ^c   Yoshikawa, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

^d Kobe Shoin Women's University   (Japan)

^e CALPIS Co Ltd   (Japan)

Author keywords

Adrenalectomy; Anti analgesic effect; Corticosterone; Enterostratin; RU486; Opioid

Indexed keywords

CORTICOSTERONE; ENTEROSTATIN; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; MU OPIATE RECEPTOR;

ADRENAL CORTEX; ADRENALECTOMY; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0041704607     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00124-4     Document Type: Article

References (28)

1. Berger K., Winzell M.S., Erlanson-Albertsson C. Binding of enterostatin to the human neuroepithelioma cell line SK-N-MC. Peptides. 19:1998;1525-1531.
2. Capasso A., Di Giannuario A., Loizzo A., Pieretti S., Sorrentino L. Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice. Life Sci. 51:1992;139-143.
3. Chen Y.Z., Qiu J. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol. Cell. Biol. Res. Commun. 2:1999;145-149.
4. Erlanson-Albertson C. The existence of pro-colipase in pancreatic juice. Biochim. Biophys. Acta. 666:1981;299-300.
5. Erlanson-Albertsson C. Pancreatic colipase. Structure and physiological aspects. Biochim. Biophys. Acta. 1125:1992;1-7.
6. Erlanson-Albertsson C., Larsson A. The activation peptide of pancreatic procolipase decreases food intake in rats. Regul. Pept. 22:1998;325-331.
7. Hylden J.L., Wilcox G.L. Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci. 33:1983;789-795.
8. Lin L., Chen J., York D.A. Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight. Peptides. 18:1997;657-661.
9. Lin L., Okada S., York D.A., Bray G.A. Structural requirements for the biological activity of enterostatin. Peptides. 15:1994;849-854.
10. Lin L., Umahara M., York D.A., Bray G.A. β-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides. 19:1998;325-331.
11. Lin L., York D.A. Metergoline blocks the feedings response to enterostatin. Appetite. 23:1994;313.
12. Lin L., York D.A. A chronic fat signal is required for enterostatin effect on food intake. FASEB J. 9:1995;A1006.
13. Lin L., York D.A. Enterostatin actions in the amygdala and PVN to suppress feeding in the rat. Peptides. 18:1997;1341-1347.
14. Lowe M.E., Rosenblum J.L., McEwen P., Strauss A.W. Cloning and characterization of the human colipase cDNA. Biochemistry. 29:1990;823-828.
15. Maggi R., Pimpinelli F., Casulari L.A., Piva F., Martini L. Antiprogestins inhibit the binding of opioids to μ-opioid receptors in nervous membrane preparations. Eur. J. Pharmacol. 301:1998;169-177.
16. Maguire P., Tsai N., Kamal J., Cometta-Morini C., Upton C., Loew G. Pharmacological profiles of fentanyl analogs at μ-, δ- and κ-opiate receptors. Eur. J. Pharmacol. 213:1992;219-225.
17. Mei J., Erlanson-Albertsson C. Role of intraduodenally administered enterostatin in rats; inhibition of food. Obesity Res. 4:1996;161-165.
18. Mizuma H., Imamura M., Tiemann W.E., Prasad C. Biology of enterostatin. II. Development of enzyme-linked immunosorbentassay (ELISA) for enterostatin (Val-Pro-Asp-Pro-Arg), the procolipase activation peptide. Biochem. Biophys. Res. Commun. 215:1995;227-234.
19. Okada S., Lin L., York D.A., Bray G.A. Chronic effects of intracerebral ventricular enterostatin in Osborne-Mendel rats fed a high-fat diet. Physiol. Behav. 54:1993;325-329.
20. Ookuma K., Barton C., York D.A., Bray G.A. Effect of enterostatin and κ-opioids on macronutrient selection and consumption. Peptides. 18:1997;785-791.
21. Payne R.M., Sims H.F., Jennes M.L., Lowe M.E. Rat pancreatic lipase and two related proteins: enzymatic properties and mRNA expression during development. Am. J. Physiol. 266:1994;G914-G921.
22. Rippe C., Erlanson-Albertson C. Identification of enterostatin and the relationship between lipase and colipase in various species. Nutr. Neurosci. 1:1998;111-117.
23. Shargill N.S., Tsujii S., Bray G.A., Erlanson-Albertsson C. Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Res. 544:1991;137-140.
24. Simonin F., Gaveriaux-Ruff C., Befort K., Matthes H., Lannes B., Micheletti G.et al. κ-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;7006-7010.
25. Takenaka Y., Nakamura F., Jinsmaa Y., Lipkowski A.W., Yoshikawa M. Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities. Biosci. Biotechnol. Biochem. 65:2001;236-238.
26. Wang J.B., Johnson P.S., Persico A.M., Hawkins A.L., Griffin C.A., Uhl G.R. Human μ-opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338:1994;217-222.
27. Wicker C., Puigserver A. Rat pancreatic colipase mRNA: nucleotide sequence of a cDNA clone and nutritional regulation by a lipidic diet. Biochem. Biophys. Res. Commun. 167:1990;130-136.
28. Wu Y.J., Hughes D., Lin L., Braymer D.H., York D.A. Comparative study of enterostatin sequence in five rat strains an enterostatin binding proteins in rat and chicken serum. Peptides. 23:2002;537-544.